Tau's Moment: A Breakthrough in Alzheimer's Research? Recent studies have shed light on the crucial role of tau in cognitive decline, a development that could potentially revolutionize treatment strategies.
While amyloid plaques have been the focus of treatment for decades, researchers are now targeting tau as a key contributor to Alzheimer's disease.
Biogen's diranersen has shown promising results in reducing tau levels, which can lead to significant cognitive benefits.